September 20, 2017
From Bulk To Bottle. Modern equipment enables a full range of DSCSA-compliant solutions for filling, blister packing, labeling and packaging pills and capsules.
A full complement of on-site packaging and labeling solutions present a range of options to increase the efficiency, control costs and enhance profitability.
Modern packaging lines are operated by experience technicians responsible for filling, bottling, blister packing and labeling tablets and capsules. Strict cGMP guidelines are followed to ensure product safety. Re-packaging and re-labeling programs allow our clients to anticipate changing demand for packaging configurations.
The 3PL pharmaceutical packaging and labeling operations at WDSrx increase convenience and maximize cost control:
Each packaging program is customized in advance to confirm all specifications and to review potential operational and cost efficiencies that are passed on to the client. Program elements include incoming, in-process and finished goods testing, batch record review, Validation Procedures and scaling production for small runs and stability batches.
The experienced WDSrx production team also tailors kitting programs from the packaging department that gather separate components and package them together before distribution to their final destination. Each kitting project requires extensive planning and precise implementation to meet the standards of clients and our internal quality control requirements.
Serialization describes the unique identification of individual cartons and bottles of medications. Specific standards are set out in the Federal Drug Supply Chain Security Act (DSCSA) that promises increased consumer safety, protection from fraud and a reduction in counterfeit drug products. The new label protocols require technology upgrades to equipment. WDSrx packaging lines are fully compliant with the DSCSA enacted regulations.
Please allow us to contact you to discuss your 3PL pharmaceutical packaging and labeling requirements.
Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at email@example.com or (561) 998-3885 x316.